Overview

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Some of the fat (triglyceride) from the food humans eat gets stored in the bowel. This triglyceride can then be released into the blood when another meal is consumed or in response to hormones. How the gut hormone glucagon-like peptide-2 (GLP-2) releases the triglyceride from the gut is not known. The research team in this study is interested in finding out how teduglutide (a degradation resistant form of GLP-2) releases stored triglyceride from the gut by studying samples from patients undergoing endoscopy and small bowel biopsy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Kensington Screening Clinic
Treatments:
Glucagon
Glucagon-Like Peptide 1
Teduglutide